Evidence map›Paper›PMID 33848521›Full record

ArticleExperimental eye research2021

Triacylglycerol lipidome from human meibomian gland epithelial cells: Description, response to culture conditions, and perspective on function.

Jillian F Ziemanski, Landon Wilson, Stephen Barnes, Kelly K Nichols

Open access · greenAbstract read
In one paragraph

Article in Experimental eye research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jillian F ZiemanskiUniversity of Alabama at Birmingham, School of Optometry, Department of Optometry and Vision Science, Birmingham, AL, USA. Electronic address: jfmead@uab.edu.
Landon WilsonUniversity of Alabama at Birmingham, School of Medicine, Department of Pharmacology and Toxicology, Birmingham, AL, USA.
Stephen BarnesUniversity of Alabama at Birmingham, School of Medicine, Department of Pharmacology and Toxicology, Birmingham, AL, USA.
Kelly K NicholsUniversity of Alabama at Birmingham, School of Optometry, Department of Optometry and Vision Science, Birmingham, AL, USA.
University of Alabama at Birmingham · US

Funding

Complement and Dry Eye Disease Associated with Primary Sjogren's SyndromeK23EY028629 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ZIEMANSKI, JILLIAN F · 2019 to 2023
$717k
5500 Q-Trap Mass SpectrometerS10RR027822 · NCRR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BARNES, STEPHEN · 2010 to 2010
$469k
NCRR NIH HHS S10 RR027822NEI NIH HHS K23 EY028629
6 · The paper itself

Abstract

Preliminary work has shown that select triacylglycerols (TAGs) are upregulated in a preclinical model of MGD, suggesting that TAGs may be an important outcome variable in research involving human meibomian gland epithelial cells (HMGECs). The purpose of this study was to explore the HMGEC TAG lipidome in culture conditions known to influence differentiation. HMGECs were differentiated in DMEM/F12 with 10 ng/ml EGF, FBS (2% or 10%), and rosiglitazone (0, 20, or 50 μM) for two or five days. Following culture, lipids were extracted, processed, and directly infused into a Triple TOF 5600 mass spectrometer (SCIEX, Framingham, MA) with electrospray ionization. MS and MS/MS

Indexed as

Cell CountCell DifferentiationCells, CulturedEpidermal Growth FactorEpithelial CellsHumansHypoglycemic AgentsLipidomicsMeibomian GlandsRosiglitazoneSerumSpectrometry, Mass, Electrospray IonizationTandem Mass SpectrometryTriglyceridesEpidermal Growth FactorHypoglycemic AgentsRosiglitazoneTriglyceridesCell cultureHuman meibomian gland epithelial cellsMass spectrometryMeibomian glandPeroxisome proliferator activator receptor-γ (PPARγ)RosiglitazoneTriacylglycerols

Identifiers

PMID33848521
PMCPMC8187311
OpenAlexW3154361791

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.